Company intelligence / Profile preview

Cadwell

Kennewick, Washington, United Statescadwell.com ↗

Ownership: Private
Employees: ~260
Development stage: Commercial

Overview

Cadwell is a leading global provider of neurodiagnostic and neuromonitoring solutions. Its portfolio includes commercialized systems for EEG, EMG/NCS/EP/NMUS diagnostics, intraoperative neuromonitoring (IONM), and sleep studies. The company’s products are widely used in clinical practice worldwide and have a strong reputation for innovation in the field of neurophysiology.

Therapeutic areas: Neurology
Modalities: Device (neurodiagnostic and neuromonitoring equipment)
Industry: Physiological Monitoring

Partnerships

Seer Medical – strategic investment to expand home-based epilepsy diagnostics

Beyond the preview

Go deeper on Cadwell.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cadwell.

Explore the full profile